First Selective Dual Inhibitors of Tau Phosphorylation and Beta-Amyloid Aggregation, Two Major Pathogenic Mechanisms in Alzheimer’s Disease
- 23 September 2014
- journal article
- letter
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 5 (12) , 1198-1202
Abstract
In Alzheimer’s disease (AD), multiple factors account for the accumulation of neurocellular changes, which may begin several years before symptoms appear. The most important pathogenic brain changes that are contributing to the development of AD are the formation of the cytotoxic β-amyloid aggregates and of the neurofibrillary tangles, which originate from amyloid-β peptides and hyperphosphorylated tau protein, respectively. New therapeutic agents that target both major pathogenic mechanisms may be particularly efficient. In this study, we introduce bis(hydroxyphenyl)-substituted thiophenes as a novel class of selective, dual inhibitors of the tau kinase Dyrk1A and of the amyloid-β aggregation.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (EN 381/3-1)
This publication has 33 references indexed in Scilit:
- Amyloid and tau in the brain in sporadic Alzheimer’s disease: defining the chicken and the eggActa Neuropathologica, 2014
- Tau protein kinases: Involvement in Alzheimer's diseaseAgeing Research Reviews, 2013
- RETRACTED: Soluble α-Synuclein Is a Novel Modulator of Alzheimer's Disease PathophysiologyJournal of Neuroscience, 2012
- Amyloid-β and tau — a toxic pas de deux in Alzheimer's diseaseNature Reviews Neuroscience, 2010
- MNB/DYRK1A as a multiple regulator of neuronal developmentThe FEBS Journal, 2010
- The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndromeActa Neuropathologica, 2008
- Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndromeThe FASEB Journal, 2008
- Dyrk1A overexpression in immortalized hippocampal cells produces the neuropathological features of Down syndromeMolecular and Cellular Neuroscience, 2007
- The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between β-amyloid production and tau phosphorylation in Alzheimer diseaseHuman Molecular Genetics, 2006
- Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndromeAnnals of Neurology, 1985